KTRA · Kintara Therapeutics
Acquired Company
TuHURA Biosciences completed its merger with Kintara Therapeutics on 10/18/2024, and the combined company operates as TuHURA Biosciences, Inc.
Kintara Therapeutics, Inc. operates as a clinical and commercial stage drug development company with a focus on the treatment of cancer. The Company focuses on identifying clinical and commercial-stage compounds and establishing a scientific rationale for development in modern orphan drug indications. Kintara Therapeutics serves customers worldwide.
12707 High Bluff Drive, Suite 200, California, 92130, US
Polish and Other Sanitation Good Manufacturing
Manufacturing
Market Cap
N/A
52 Wk Range
N/A - N/A
Previous Close
$1.93
Open
$1.95
Volume
148,974
Day Range
$1.95 - $1.99
Enterprise Value
N/A
Cash
N/A
Avg Qtr Burn
N/A
Insider Ownership
0.12%
Institutional Own.
1.47%
Qtr Updated
Jun 30th 2024